Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : XENE exchanges : Nasdaq save search
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-16 (Crawled : 13:00) - globenewswire.com
XENE | $39.46 -3.97% -4.13% 330K
|
Health Technology
|
| O: 0.0%
H: 1.73%
C: 0.44%
xen1101 neurology pharmaceuticals meeting
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Published: 2024-04-10 (Crawled : 12:30) - globenewswire.com
XENE | $39.46 -3.97% -4.13% 330K
|
Health Technology
|
| O: -1.05%
H: 1.69%
C: -0.35%
conference pharmaceuticals
Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-04 (Crawled : 20:00) - globenewswire.com
XENE | $39.46 -3.97% -4.13% 330K
|
Health Technology
|
| O: -0.4%
H: 1.57%
C: 0.5%
conference pharmaceuticals
Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days
Published: 2024-03-12 (Crawled : 20:00) - globenewswire.com
XENE | $39.46 -3.97% -4.13% 330K
|
Health Technology
|
| O: 0.34%
H: 1.7%
C: 1.53%
pharmaceuticals
Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024
Published: 2024-03-05 (Crawled : 21:00) - globenewswire.com
XENE | $39.46 -3.97% -4.13% 330K
|
Health Technology
|
| O: 0.0%
H: 3.13%
C: -0.09%
conference biopharma pharmaceuticals global
Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-02-29 (Crawled : 21:00) - globenewswire.com
XENE | $39.46 -3.97% -4.13% 330K
|
Health Technology
|
| O: 5.3%
H: 2.6%
C: -5.75%
year update pharmaceuticals financial results
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
Published: 2024-02-22 (Crawled : 21:00) - globenewswire.com
XENE | $39.46 -3.97% -4.13% 330K
|
Health Technology
|
| O: -0.08%
H: 0.61%
C: 0.51%
conference year update pharmaceuticals financial results
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024
Published: 2024-01-08 (Crawled : 13:00) - globenewswire.com
XENE | $39.46 -3.97% -4.13% 330K
|
Health Technology
|
| O: -0.53%
H: 6.05%
C: 5.79%
pharmaceuticals key milestone
Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-03 (Crawled : 14:00) - globenewswire.com
XENE | $39.46 -3.97% -4.13% 330K
|
Health Technology
|
| O: -0.47%
H: 0.47%
C: -1.14%
conference pharmaceuticals
Xenon Pharmaceuticals Announces Closing of $345.0 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Published: 2023-12-04 (Crawled : 21:00) - globenewswire.com
XENE | $39.46 -3.97% -4.13% 330K
|
Health Technology
|
| O: 0.4%
H: 2.35%
C: 2.19%
offering pharmaceuticals
Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2023)
Published: 2023-12-02 (Crawled : 20:20) - globenewswire.com
XENE | $39.46 -3.97% -4.13% 330K
|
Health Technology
| Email alert
Add to watchlist
FNCTF | News | $11.16 -20.84% 130
|
Communications
| Email alert
Add to watchlist
pipeline pharmaceuticals meeting
Xenon Pharmaceuticals Announces Pricing of Upsized $300.0 Million Public Offering
Published: 2023-11-30 (Crawled : 05:00) - globenewswire.com
XENE | $39.46 -3.97% -4.13% 330K
|
Health Technology
|
| O: 5.04%
H: 7.59%
C: 3.19%
offering pharmaceuticals
Xenon Forging Ahead in MDD Despite Mid-stage Flop
Published: 2023-11-27 (Crawled : 21:00) - biospace.com/
XENE | $39.46 -3.97% -4.13% 330K
|
Health Technology
|
| O: 0.1%
H: 18.14%
C: 17.66%
Xenon Pharmaceuticals Announces Topline Results from Phase 2 Proof-of-Concept X-NOVA Clinical Trial of XEN1101 in Major Depressive Disorder (MDD)
Published: 2023-11-27 (Crawled : 12:00) - globenewswire.com
XENE | $39.46 -3.97% -4.13% 330K
|
Health Technology
|
| O: 0.1%
H: 18.14%
C: 17.66%
xen1101 pharmaceuticals topline trial results
Xenon Pharmaceuticals Provides Update on Partnered Program with Neurocrine Biosciences
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
XENE | $39.46 -3.97% -4.13% 330K
|
Health Technology
|
| O: -1.17%
H: 2.36%
C: -2.77%
NBIX | News 4 | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: -5.22%
H: 1.98%
C: 0.82%
update pharmaceuticals program
Xenon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-11-08 (Crawled : 21:00) - globenewswire.com
XENE | $39.46 -3.97% -4.13% 330K
|
Health Technology
|
| O: 3.95%
H: 2.47%
C: -10.23%
update pharmaceuticals financial results
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Corporate Update
Published: 2023-11-01 (Crawled : 20:00) - globenewswire.com
XENE | $39.46 -3.97% -4.13% 330K
|
Health Technology
|
| O: 1.06%
H: 4.96%
C: 4.82%
conference update pharmaceuticals financial results
Xenon Pharmaceuticals Announces Publication of Results from XEN1101 Phase 2b “X-TOLE” Clinical Trial in Peer-Reviewed Journal Article in JAMA Neurology
Published: 2023-10-09 (Crawled : 20:00) - globenewswire.com
XENE | $39.46 -3.97% -4.13% 330K
|
Health Technology
|
| O: 0.31%
H: 3.31%
C: 3.06%
xen1101 publication pharmaceuticals trial results
New Investigational Drug Offers Relief for Treatment-Resistant Epilepsy Patients
Published: 2023-10-09 (Crawled : 15:00) - prnewswire.com
XENE | $39.46 -3.97% -4.13% 330K
|
Health Technology
|
| O: -0.62%
H: 1.44%
C: 0.28%
drug
Xenon Pharmaceuticals to Present at Jefferies Inaugural Biotech CNS/Neuro Summit
Published: 2023-10-06 (Crawled : 12:30) - globenewswire.com
XENE | $39.46 -3.97% -4.13% 330K
|
Health Technology
|
| O: 0.06%
H: 1.96%
C: 1.19%
biotech pharmaceuticals
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.